{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:29:58Z","timestamp":1780417798637,"version":"3.54.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"suppl_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1093\/ndt\/gfu091","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T15:44:10Z","timestamp":1409154250000},"page":"iv26-iv32","source":"Crossref","is-referenced-by-count":14,"title":["Building a network of ADPKD reference centres across Europe: the EuroCYST initiative"],"prefix":"10.1093","volume":"29","author":[{"given":"Katja","family":"Petzold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T.","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Devuyst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"K\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Pirson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sandford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik","family":"Ecder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Chaveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Torra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Le Meur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf P.","family":"W\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,9]]},"reference":[{"key":"key\n\t\t\t\t20170515175508_GFU091C1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515175508_GFU091C2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00467-012-2370-y","article-title":"Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease","volume":"28","author":"Liebau","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2215\/CJN.00780110","article-title":"Renal function and healthcare costs in patients with polycystic kidney disease","volume":"5","author":"Lentine","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175508_GFU091C6","doi-asserted-by":"crossref","first-page":"p1","DOI":"10.1159\/000112495","article-title":"Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment","volume":"108","author":"Chang","year":"2008","journal-title":"Nephron Physiol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000104818","article-title":"Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease","volume":"30","author":"Wu","year":"2007","journal-title":"Kidney Blood Press Res"},{"key":"key\n\t\t\t\t20170515175508_GFU091C8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.26140","article-title":"Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases","volume":"58","author":"Masyuk","year":"2013","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170515175508_GFU091C9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170515175508_GFU091C10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515175508_GFU091C11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515175508_GFU091C12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C13","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515175508_GFU091C14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","article-title":"Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial","volume":"382","author":"Caroli","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515175508_GFU091C15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","article-title":"Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes","volume":"1","author":"Grantham","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000341263","article-title":"Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: implications for prevention and treatment","volume":"36","author":"Helal","year":"2012","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Consortium for radiologic imaging studies of polycystic kidney disease cohort: renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175508_GFU091C19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2008.558","article-title":"Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months","volume":"75","author":"Kistler","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170515175508_GFU091C20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170515175508_GFU091C22","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","article-title":"ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515175508_GFU091C23","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1291\/hypres.31.1101","article-title":"Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods","volume":"31","author":"Imai","year":"2008","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t20170515175508_GFU091C25","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/ndt\/gfr456","article-title":"The German Chronic Kidney Disease (GCKD) study: design and methods","volume":"27","author":"Eckardt","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170515175508_GFU091C26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2190\/D7VA-FWEU-JN5Y-TD3E","article-title":"Depression, perception of illness and mortality in patients with end-stage renal disease","volume":"21","author":"Peterson","year":"1991","journal-title":"Int J Psychiatry Med"},{"key":"key\n\t\t\t\t20170515175508_GFU091C27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.V4112","article-title":"Survival in hemodialysis patients: the role of depression","volume":"4","author":"Kimmel","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170515175508_GFU091C28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1073-4449(12)80001-X","article-title":"Psychosocial issues in end-stage renal disease: introduction","volume":"1","author":"Devins","year":"1994","journal-title":"Adv Ren Replace Ther"},{"key":"key\n\t\t\t\t20170515175508_GFU091C29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2013.08.017","article-title":"Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1\u20134: a cross-sectional study","volume":"63","author":"Miskulin","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170515175508_GFU091C30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ndt\/gfr764","article-title":"The ERA-EDTA Working Group on inherited kidney disorders","volume":"27","author":"Devuyst","year":"2012","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/29\/suppl_4\/iv26\/17109283\/gfu091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T18:25:12Z","timestamp":1650047112000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfu091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":30,"journal-issue":{"issue":"suppl_4","published-online":{"date-parts":[[2014,9]]},"published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfu091","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}